Clinical Trial: Sustained Release Oral Formulation For Treatment Of Parkinsons Disease

U.S., July 17 -- ClinicalTrials.gov registry received information related to the study (NCT07709741) titled 'Sustained Release Oral Formulation For Treatment Of Parkinsons Disease' on July 06.

Brief Summary: LD/CD (medications to treat Parkinson's disease) will be delivered using an assembly of nested sachets made of permeable material. The assembly is placed in the oral/buccal cavity (between cheek and gum of lower jaw) and delivers continuous release of CD and LD for both transmucosal and gastrointestinal absorption. The combination of CD/LD in the inner sachet varies from that in the outer sachet. This allows for sequential release of CD and then LD to mimic a CD pretreatment method which is known to increase LD absorption and prolong i...